Clinical characteristics, patient selection and clinical outcomes of tafamidis treatment in transthyretin amyloidosis cardiomyopathy
26 August 2022 (08:00 - 19:30)
Organised by:
About the speaker
Kumamoto University, Kumamoto (Japan)
6 More presentations in this session
Assistant Professor A. Briasoulis (Athens, GR)
Doctor S. Manjunath (Saint Louis, US)
Professor R. Witteles (Stanford, US)
Doctor M. Ungericht (Innsbruck, AT)
Associate Professor G. Polzl (Innsbruck, AT)
Access the full session
The Event
ESC Congress 2022
26 August - 29 August 2022
